Impax Asset Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Impax Asset Management's CELG Position: Q1 2018 in Review
Impax Asset Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 134,085 shares — an estimated $14M sold.
Impax Asset Management first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $28.1M in Q4 2014. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.
- Impax Asset Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
- Impax Asset Management sold 134,085 Celgene Corp shares in Q1 2018, an estimated $14M.
- Impax Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
- Impax Asset Management's Celgene Corp position peaked at $28.1M in Q4 2014.
- 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.
Based on Impax Asset Management's 13F filing for Q1 2018, filed 14 May 2018.